This page in English
Laddar profil information

Om mig

Min akademiska bakgrund innefattar en magisterexamen i medicinsk vetenskap vid Uppsala universitetet, där studerade vid läkarlinjen och examinerades som läkare från samma universitet år 2000. Jag disputerade vid enheten för klinisk epidemiologi (KEP), Karolinska Institutet år 2010, när jag försvarade avhandlingen ”Epidemiologiska studier på självmordsbenägna patienter med psykiatriska sjukdomar”. År 2016 utnämndes jag till docent i psykiatri vid Karolinska Institutet.

Efter min läkarutbildning har jag arbetat som läkare bl a i Stockholm, Gävle, Östersund och Arendal i Norge. Jag blev legitimerad läkare 2003, varpå jag genomgick specialistutbildning i psykiatri vid Psykiatri Nordväst, Karolinska Universitetssjukhuset i Stockholm. Sedan jag blivit specialist i psykiatri 2011 har jag varit överläkare vid denna klinik. Jag har även varit studierektor för Forskarskolan för kliniker inom epidemiologi vid KI/SLL mellan 2014-2016.

Bland mina uppgifter vid Centrum för läkemedelsepidemiologi (CPE) ingår att vara forskare, forskningskoordinator och gruppledare för profilområdet ”CNS och läkemedel”. Genom forskning strävar jag efter att öka vår kunskap inom psykiatri och centrala nervsystemets sjukdomar genom att använda epidemiologiska metoder i stora register-baserade studier.

 

Publikationer

Antidepressant use in Denmark, Germany, Spain, and Sweden between 2009 and 2014: Incidence and comorbidities of antidepressant initiators
Forns J, Pottegård A, Reinders T, Poblador-plou B, Morros R, Brandt L, et al
Journal of affective disorders 2019;249():242-252

Marriage and divorce after military deployment to Afghanistan: A matched cohort study from Sweden
Pethrus Cm, Reutfors J, Johansson K, Neovius K, Söderling J, Neovius M, et al
PloS one 2019;14(2):e0207981-

Risk of Acute Liver Injury in Agomelatine and Other Antidepressant Users in Four European Countries: A Cohort and Nested Case-Control Study Using Automated Health Data Sources
Pladevall-vila M, Pottegård A, Schink T, Reutfors J, Morros R, Poblador-plou B, et al
CNS drugs 2019;33(4):383-395

Treatment-resistant depression as risk factor for substance use disorders-a nation-wide register-based cohort study
Brenner P, Brandt L, Li G, Dibernardo A, Bodén R, Reutfors J
Addiction (Abingdon, England) 2019;():-

Trends in utilization and dosing of antipsychotic drugs in Scandinavia: Comparison of 2006 and 2016
Højlund M, Pottegård A, Johnsen E, Kroken Ra, Reutfors J, Munk-jørgensen P, et al
British journal of clinical pharmacology 2019;():-

Violent crime among Swedish military veterans after deployment to Afghanistan: a population-based matched cohort study
Pethrus Cm, Frisell T, Reutfors J, Johansson K, Neovius K, Söderling Jk, et al
International journal of epidemiology 2019;():-

Association Between Methylphenidate and Amphetamine Use in Pregnancy and Risk of Congenital Malformations: A Cohort Study From the International Pregnancy Safety Study Consortium
Huybrechts Kf, Bröms G, Christensen Lb, Einarsdóttir K, Engeland A, Furu K, et al
JAMA psychiatry 2018;75(2):167-175

Humanistic outcomes in treatment resistant depression: a secondary analysis of the STAR*D study
Dibernardo A, Lin X, Zhang Q, Xiang J, Lu L, Jamieson C, et al
BMC psychiatry 2018;18(1):352-

Initiation and long-term use of benzodiazepines and Z-drugs in bipolar disorder
Wingård L, Taipale H, Reutfors J, Westerlund A, Bodén R, Tiihonen J, et al
Bipolar disorders 2018;20(7):634-646

Mortality in treatment-resistant unipolar depression: A register-based cohort study in Sweden
Reutfors J, Andersson Tm, Brenner P, Brandt L, Dibernardo A, Li G, et al
Journal of affective disorders 2018;238():674-679

Suicide Ideation and Behavior as Risk Factors for Subsequent Suicide in Schizophrenia: A Nested Case-Control Study
Clapham E, Bodén R, Brandt L, Jönsson Eg, Bahmanyar S, Ekbom A, et al
Suicide & life-threatening behavior 2018;():-

β-Blocker Use in Pregnancy and the Risk for Congenital Malformations: An International Cohort Study
Bateman Bt, Heide-jørgensen U, Einarsdóttir K, Engeland A, Furu K, Gissler M, et al
Annals of internal medicine 2018;169(10):665-673

International trends in antipsychotic use: A study in 16 countries, 2005-2014
Hálfdánarson Ó, Zoëga H, Aagaard L, Bernardo M, Brandt L, Fusté Ac, et al
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2017;27(10):1064-1076

International trends in clozapine use: a study in 17 countries
Bachmann Cj, Aagaard L, Bernardo M, Brandt L, Cartabia M, Clavenna A, et al
Acta psychiatrica Scandinavica 2017;136(1):37-51

Reducing the rehospitalization risk after a manic episode: A population based cohort study of lithium, valproate, olanzapine, quetiapine and aripiprazole in monotherapy and combinations
Wingård L, Bodén R, Brandt L, Tiihonen J, Tanskanen A, Kieler H, et al
Journal of affective disorders 2017;217():16-23

Risk of breast cancer in risperidone users: A nationwide cohort study
Reutfors J, Wingård L, Brandt L, Wang Y, Qiu H, Kieler H, et al
Schizophrenia research 2017;182():98-103

Season of treatment initiation with antidepressants and suicidal behavior: A population-based cohort study in Sweden
Makris Gd, Reutfors J, Andersen M, White Ra, Ekselius L, Papadopoulos Fc
Journal of affective disorders 2017;215():245-255

Suicide and all-cause mortality in Swedish deployed military veterans: a population-based matched cohort study
Pethrus Cm, Johansson K, Neovius K, Reutfors J, Sundström J, Neovius M
BMJ open 2017;7(9):e014034-

Serotonergic medication enhances the association between suicide and sunshine
Makris Gd, Reutfors J, Larsson R, Isacsson G, Ösby U, Ekbom A, et al
Journal of affective disorders 2016;189():276-81

Suicide risk and antipsychotic side effects in schizophrenia: nested case-control study
Reutfors J, Clapham E, Bahmanyar S, Brandt L, Jönsson Eg, Ekbom A, et al
Human psychopharmacology 2016;31(4):341-5

Diabetes and glucose disturbances in patients with psychosis in Sweden
Olsson E, Westman J, Sudic Hukic D, Eriksson Sv, Edman G, Bodén R, et al
BMJ open diabetes research & care 2015;3(1):e000120-

Predictors for initiation of pharmacological prophylaxis in patients with newly diagnosed bipolar disorder-A nationwide cohort study
Scheen L, Brandt L, Boden R, Tiihonen J, Andersen M, Kieler H, et al
JOURNAL OF AFFECTIVE DISORDERS 2015;:204-10

Risk and predictors of attempted and completed suicide in patients with hematological malignancies
Mohammadi M, Moradi T, Bottai M, Reutfors J, Cao Y, Smedby Ke
Psycho-oncology 2014;23(11):1276-82

Suicide in first episode psychosis: a nationwide cohort study
Björkenstam C, Björkenstam E, Hjern A, Bodén R, Reutfors J
Schizophrenia research 2014;157(1-3):1-7

A comparison of cardiovascular risk factors for ten antipsychotic drugs in clinical practice
Boden R, Edman G, Reutfors J, Ostenson Cg, Osby U
NEUROPSYCHIATRIC DISEASE AND TREATMENT 2013;:371-7

A five year diagnostic follow-up of 1,840 patients after a first episode non-schizophrenia and non-affective psychosis
Björkenstam E, Björkenstam C, Hjern A, Reutfors J, Bodén R
Schizophrenia research 2013;150(1):205-10

Antipsychotic prescription filling in patients with schizophrenia or schizoaffective disorder
Reutfors J, Brandt L, Stephansson O, Kieler H, Andersen M, Bodén R
Journal of clinical psychopharmacology 2013;33(6):759-65

Medication and suicide risk in schizophrenia: a nested case-control study
Reutfors J, Bahmanyar S, Jönsson Eg, Brandt L, Bodén R, Ekbom A, et al
Schizophrenia research 2013;150(2-3):416-20

Suicide seasonality and antidepressants: a register-based study in Sweden
Makris Gd, Reutfors J, Ösby U, Isacsson G, Frangakis C, Ekbom A, et al
Acta psychiatrica Scandinavica 2013;127(2):117-25

Antipsychotics during pregnancy: relation to fetal and maternal metabolic effects
Bodén R, Lundgren M, Brandt L, Reutfors J, Kieler H
Archives of general psychiatry 2012;69(7):715-21

Risks of adverse pregnancy and birth outcomes in women treated or not treated with mood stabilisers for bipolar disorder: population based cohort study
Bodén R, Lundgren M, Brandt L, Reutfors J, Andersen M, Kieler H
BMJ (Clinical research ed.) 2012;345():e7085-

Early non-adherence to medication and other risk factors for rehospitalization in schizophrenia and schizoaffective disorder
Boden R, Brandt L, Kieler H, Andersen M, Reutfors J
SCHIZOPHRENIA RESEARCH 2011;133(1-3):36-41

Diagnostic profile and suicide risk in schizophrenia spectrum disorder
Reutfors J, Bahmanyar S, Jonsson Eg, Ekbom A, Nordstrom P, Brandt L, et al
SCHIZOPHRENIA RESEARCH 2010;123(2-3):251-6

Suicide and hospitalization for mental disorders in Sweden: A population-based case-control study
Reutfors J, Brandt L, Ekbom A, Isacsson G, Sparen P, Osby U
JOURNAL OF PSYCHIATRIC RESEARCH 2010;44(12):741-7

Risk factors for suicide in schizophrenia: Findings from a Swedish population-based case-control study
Reutfor J, Brandt L, Jonsson Eg, Ekbom A, Sparen P, Osby U
SCHIZOPHRENIA RESEARCH 2009;108(1-3):231-7

Seasonality of suicide in Sweden: Relationship with psychiatric disorder
Reutfors J, Osby U, Ekbom A, Nordstrom P, Jokinen J, Papadopoulos Fc
JOURNAL OF AFFECTIVE DISORDERS 2009;119(1-3):59-65

Coeliac disease and risk of mood disorders - A general population-based cohort study
Ludvigsson Jf, Reutfors J, Osby U, Ekbom A, Montgomery Sm
JOURNAL OF AFFECTIVE DISORDERS 2007;99(1-3):117-26

[Coming generation of researchers--a question of fate for psychiatry]
Cervenka S, Reutfors J, Lundberg J, Papadopoulos F, Lundén E, Sjöström C, et al
Lakartidningen 2007;104(26-27):2002-3

Central nervous system tumours in children in Costa Rica, 1981-96
Reutfors J, Kramarova E, Weiderpass E, Monge P, Wesseling C, Ahlbom A
PAEDIATRIC AND PERINATAL EPIDEMIOLOGY 2002;16(3):219-25

Childhood leukaemia in Costa Rica, 1981-96
Monge P, Wesseling C, Rodriguez Ac, Cantor Kp, Weiderpass E, Reutfors J, et al
PAEDIATRIC AND PERINATAL EPIDEMIOLOGY 2002;16(3):210-8

Visa alla publikationer